Aurora Cannabis Inc. (NYSE:ACB) Given Average Rating of “Hold” by Analysts

Aurora Cannabis Inc. (NYSE:ACBGet Rating) has earned a consensus rating of “Hold” from the nine research firms that are presently covering the company, Marketbeat reports. Three analysts have rated the stock with a sell rating and four have assigned a hold rating to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $5.53.

A number of equities analysts recently commented on the stock. Zacks Investment Research raised shares of Aurora Cannabis from a “sell” rating to a “hold” rating in a research note on Monday, January 31st. Cantor Fitzgerald lowered their price objective on shares of Aurora Cannabis from C$7.60 to C$3.90 in a research report on Friday, May 13th. Finally, CIBC lowered their price objective on shares of Aurora Cannabis from C$6.50 to C$3.75 in a research report on Monday, May 16th.

A number of institutional investors have recently modified their holdings of ACB. Citigroup Inc. boosted its holdings in shares of Aurora Cannabis by 684.4% in the 3rd quarter. Citigroup Inc. now owns 6,048 shares of the company’s stock valued at $42,000 after acquiring an additional 5,277 shares during the last quarter. Horan Securities Inc. purchased a new stake in shares of Aurora Cannabis in the 4th quarter valued at $54,000. PFG Advisors purchased a new stake in shares of Aurora Cannabis in the 4th quarter valued at $56,000. Spire Wealth Management boosted its holdings in Aurora Cannabis by 73.0% during the fourth quarter. Spire Wealth Management now owns 10,384 shares of the company’s stock worth $56,000 after buying an additional 4,382 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new stake in Aurora Cannabis during the third quarter worth $77,000. Institutional investors and hedge funds own 15.47% of the company’s stock.

ACB stock opened at $2.93 on Monday. Aurora Cannabis has a 12 month low of $2.20 and a 12 month high of $10.64. The company has a current ratio of 5.85, a quick ratio of 3.70 and a debt-to-equity ratio of 0.32. The company has a 50-day moving average price of $3.34 and a 200 day moving average price of $4.64. The stock has a market cap of $657.29 million, a PE ratio of -0.63 and a beta of 2.86.

About Aurora Cannabis (Get Rating)

Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.

Read More

Analyst Recommendations for Aurora Cannabis (NYSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.